ONCOLOGY: Ibritumomab Provides Benefit in Patients with Follicular Lymphoma

Audio Journal of Oncology, December 10th, 2007 Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta Ibritumomab Provides Benefit in Patients with Follicular Lymphoma ANTON HAGENBEEK, University Medical Centre Utrecht REFERENCE: ABSTRACT 643, ASH 2007 For patients with advanced-stage follicular non-Hodgkin’s lymphoma, ibritumomab tiuxetan seems to prolong progression free survival by two years with favourable toxicity. Sarah Maxwell spoke to study author Anton Hagenbeek at the ASH meeting in Atlanta while George Canellos provided comment.

You can listen to ONCOLOGY: Ibritumomab Provides Benefit in Patients with Follicular Lymphoma online on Radio and Podcast. Open the player on this page to stream the available audio.

ONCOLOGY: Ibritumomab Provides Benefit in Patients with Follicular Lymphoma is an episode from Audio Medica News - Medical News Interviews by Audio Medica.

This episode is 00:07:40 long.

This episode was published on Dec 10, 2007.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Audio Medica News - Medical News Interviews when more episodes are available from the podcast feed.